Evidence map›Paper›PMID 26503619›Full record

ArticleBMC infectious diseases2015

Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) and proteinuria predict severity of acute kidney injury in Puumala virus infection.

Hanno Bunz, Peter Weyrich, Andreas Peter, Dorothea Baumann, Otto Tschritter, Martina Guthoff, Robert Beck, Gerhard Jahn, Ferruh Artunc, Hans-Ulrich Häring and 2 more

Open access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Hanno BunzDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of the Eberhard Karls University, Tübingen, Germany. hanno.bunz@med.uni-tuebingen.de.
Peter WeyrichDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of the Eberhard Karls University, Tübingen, Germany. pweyrich@hotmail.com.
Andreas PeterDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of the Eberhard Karls University, Tübingen, Germany. andreas.peter@med.uni-tuebingen.de.
Dorothea BaumannDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of the Eberhard Karls University, Tübingen, Germany. dorothea.baumann@med.uni-tuebingen.de.
Otto TschritterDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of the Eberhard Karls University, Tübingen, Germany. otto.tschritter@vinzenz.de.
Martina GuthoffDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of the Eberhard Karls University, Tübingen, Germany. martina.guthoff@med.uni-tuebingen.de.
Robert BeckInstitute of Medical Virology and Epidemiology of Viral Diseases, Eberhard Karls University, Tübingen, Germany. robert.beck@med.uni-tuebingen.de.
Gerhard JahnInstitute of Medical Virology and Epidemiology of Viral Diseases, Eberhard Karls University, Tübingen, Germany. gerhard.jahn@med.uni-tuebingen.de.
Ferruh ArtuncDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of the Eberhard Karls University, Tübingen, Germany. ferruh.artunc@med.uni-tuebingen.de.
Hans-Ulrich HäringDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of the Eberhard Karls University, Tübingen, Germany. hans-ulrich.haering@med.uni-tuebingen.de.
Nils HeyneDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of the Eberhard Karls University, Tübingen, Germany. nils.heyne@med.uni-tuebingen.de.
Robert WagnerDepartment of Internal Medicine, Division of Endocrinology, Diabetology, Nephrology, Vascular Disease and Clinical Chemistry, University Hospital of the Eberhard Karls University, Tübingen, Germany. robert.wagner@med.uni-tuebingen.de.
University of Tübingen · DEGerman Center for Diabetes Research · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNephropathia epidemica (NE) is a mild form of hemorrhagic fever with renal syndrome (HFRS) that is caused by the Puumala virus. Periodic outbreaks have been described in endemic areas, with a substantial number of previously healthy individuals developing acute kidney injury (AKI). There is a considerable diversity in the clinical course of the disease, and few patients require renal replacement therapy.

methodsWe tested whether urinary neutrophil gelatinase associated lipocalin (uNGAL), urine albumin/creatinine ratio (uACR), urine protein/creatinine ratio (uPCR), urine dipstick protein, C-reactive protein, procalcitonin, leukocyte and platelet count, determined on admission to the hospital, can predict the severity of AKI. Sixty-one patients were analyzed during admission in the emergency department.

resultsThe variables most strongly associated with peak plasma creatinine concentration were uNGAL (β = 0.70, p <0.0001), uPCR (β = 0.64, p = 0.001), uACR (β = 0.61, p = 0.002), and dipstick proteinuria (β = 0.34, p = 0.008). The highest AUC-ROC to predict stage 3 AKI according to the acute kidney injury network's (AKIN) classification was seen for uNGAL (0.81, p = 0.001).

conclusionuNGAL accurately predicts the severity of AKI in NE. This could help emergency room physicians predict disease severity and allow for initial risk stratification.

Indexed as

Acute Kidney InjuryAcute-Phase ProteinsAdultAlbuminuriaBiomarkersCalcitoninCalcitonin Gene-Related PeptideC-Reactive ProteinCreatinineEmergency Service, HospitalFemaleHemorrhagic Fever with Renal SyndromeHumansLipocalin-2LipocalinsMaleAcute-Phase ProteinsBiomarkersCALCA protein, humanCalcitoninCalcitonin Gene-Related PeptideC-Reactive ProteinCreatinineLCN2 protein, humanLipocalin-2LipocalinsProtein PrecursorsProto-Oncogene Proteins

Identifiers

PMID26503619
PMCPMC4621931
OpenAlexW1819891023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.